Overview

Drug-Drug Interaction Study of Vadadustat With Cyclosporine, Probenecid and Rifampin

Status:
Completed
Trial end date:
2018-08-15
Target enrollment:
Participant gender:
Summary
This is a Phase 1, two-part, open-label study to evaluate the interaction of cyclosporine, probenecid, and rifampin as perpetrators with vadadustat (victim) in healthy male and female subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Akebia Therapeutics
Treatments:
Cyclosporine
Cyclosporins
Probenecid
Rifampin